TRU-SENTIMENT · DeltaNeutral
ACAD Trading Analysis - 09/17/2026 01:36 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $27.46. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $4,195,925 vs put $0. RSI 26.0.
- Symbol
- ACAD
- Price
- $27.46
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-09-17 13:36:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Options flow sentiment is bullish, with a call dollar volume of $4,195,925 and no put dollar volume. This suggests strong directional conviction among traders.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 12.35 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 7.26 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment (Source: Company Press Release)
- Analysts raise price targets for ACAD following strong quarterly earnings (Source: Bloomberg)
- ACAD's drug pipeline shows promise with several new clinical trials initiated (Source: Reuters)
These headlines suggest a positive outlook for ACAD, with potential catalysts from new treatment approvals and strong earnings performance.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $11,386,430,000
- Trailing EPS: $2.23
- Trailing P/E: 12.35
- Debt/Equity: 0.33
- Return on Equity (ROE): 29.12%
ACAD's fundamentals indicate a strong revenue base and healthy profitability metrics. The debt-to-equity ratio suggests manageable leverage, and the ROE indicates efficient use of shareholder capital.
Current Market Position:
Current price: $27.46
Recent price action shows a slight decline, but the stock is still trading near its recent range.
Technical Analysis:
Technical Indicators
SMA trends indicate a neutral to slightly bearish alignment, with the 50-day SMA above the current price. RSI is in oversold territory, suggesting potential for a bounce. MACD shows a bearish signal.
True Sentiment Analysis (Delta 40-60 Options):
Options flow sentiment is bullish, with a call dollar volume of $4,195,925 and no put dollar volume. This suggests strong directional conviction among traders.
Key Price Levels:
Key support and resistance levels are $26.64 and $30.96, respectively. These levels may act as barriers or targets for the stock price.
25-Day Price Forecast:
Based on current technical trends, momentum, and indicators, ACAD is projected for $25.50 to $30.20.
Defined Risk Strategy Recommendations:
- Buy 26.0 Call, Sell 28.0 Call, Expiration: 2026-10-16
- Sell 27.0 Put, Buy 25.0 Put, Expiration: 2026-10-16
- Iron Condor: Buy 25.0 Put, Sell 26.0 Put, Sell 28.0 Call, Buy 30.0 Call, Expiration: 2026-10-16
These strategies align with the projected price range and offer defined risk profiles.
Risk Factors:
- Technical warning signs: RSI oversold, MACD bearish
- Sentiment divergences: bullish options flow vs bearish technicals
- Volatility and ATR considerations: recent price swings
These factors could impact the stock price and trading strategies.
Summary & Conviction Level:
Overall bias: Neutral
Conviction level: Medium
One-line trade idea: Monitor technical and sentiment alignment for directional trades.
View ACAD Options Chain